Krishna Institute of Medical Sciences Ltd: Value Pick Stock October 2022
The Krishna Institute of Medical Sciences Limited (KIMS) is an Indian hospital chain based in Telangana.
Krishna Institute of Medical Sciences: History
- The very first hospital from the KIMS Group was founded in the year 2000 at Nellore (Andhra Pradesh) by Dr. Bhaskar Rao Bollineni (a cardiac surgeon) who has performed 30,000 plus surgeries.
- In the year 2004, KIMS group’s flagship hospital, krishna institute of medical sciences, secunderabad hospital was established, which is now a 1000-bedded hospital.
- In the year 2015, KIMS Hospital received the first “Green Operation Theater” certification in Telangana and Andhra Pradesh.
- The company successfully raised INR 2170 Cr through krishna institute of medical sciences limited ipo in the year 2021 and became a publicly listed company.
Krishna Institute of Medical Sciences: Business
(KIMS) Hospitals is one of the largest corporate healthcare groups in India with hospitals in Andhra Pradesh, Telangana, and Maharashtra.
The Company offers a bouquet of comprehensive healthcare services across 25 specialties including Cardiology, Cardiothoracic and Cardiovascular surgery, Dermatology, Dental, Diabetology, ENT, Gastroenterology, Oncology, Nephrology, Neurology, Neurosurgery, Obstetrics & Gynecology, Organ Transplantation, Orthopedics, Pediatrics, Pulmonology, Plastic Surgery, Rheumatology, Robotics and Urology.
The KIMS Hospital Group is certified by NABH (National Accreditation Board for Hospitals) and NABL (National Accreditation Board for Testing and Calibration Laboratories).
Total Bed Capacity
The company operates 13 multi-specialty hospitals across the states of Andhra Pradesh, Telangana, and Maharashtra under the KIMS Hospitals brand, with an aggregate bed capacity of 4000.
The KIMS Group has hospitals in Secunderabad, Hyderabad, Visakhapatnam, Nagpur, Kondapur, Ongole, Rajahmundry, Srikakulam, Nellore, Anantapur, and Kurnool.
Affordable Pricing Model
The Company has successfully implemented its affordable pricing model in its hospitals.
In Tier 1 cities, their prices across medical procedures are on average 20 to 30 percent lower than other private hospitals in the country.
In FY22, their Analysis of ROI for Pharmaceutical Promotion (ARPP) is INR 121,232, which has improved from INR 84,388 in FY18.
Listed On:
The share of Krishna Institute of Medical Sciences Ltd is presently listed on the Bombay Stock Exchange (BSE); CODE 543308 and National Stock Exchange (NSE) as KIMS
Stock Info: Krishna Institute of Medical Sciences
Share Holding Pattern
Financials
Conclusion
KIMS is one of the largest corporate healthcare groups in India; providing multi-disciplinary integrated healthcare services at an affordable cost.
Promoters of the company are having more than 38 percent stake.
Along with this, some of the top institutions like Nomura India Investment Fund Mother Fund, Mirae Asset Emerging Bluechip Fund, Axis Mutual Fund Trustee Limited, India Advantage Fund, Hdfc Life Insurance Company Limited, Tata AIA Life Insurance Co Ltd, and General Atlantic Singapore Kh Pte Ltd is having more than a 1% stake in the company (as of June 2022).
Krishna Institute of Medical Sciences consolidated numbers for June 2022; Net Sales at INR 495.5 Cr (UP 4.8% Y-O-Y and 33% Q-O-Q) while Net Profit at INR 79.25 Cr
On the technical front, KIMS share is trading above its 20 EMA (1361) and 50 EMA (1297) on the daily chart.
Keeping the above-listed factors in mind, KIMS looks good at INR 1450. Finblab recommends investing in the stock in a staggered manner for the medium to the long haul (3 to 5 years period).
Also Read: Can Fin Homes Limited – Value Pick Stock September 2022
Disclaimer: The contents and data presented here are just for your information & personal use only. While much effort is made to provide the information, I (Vishal Dalwadi) or “FinBlab” do not guarantee the accuracy, correctness, completeness or reliability of any information or data displayed herein and shall not be held responsible.
